US › Healthcare

Talphera Inc. (TLPH)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.08+0.93%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-4.3M

EPS

$-0.06

EPS estimate

$-0.07

EPS came in at -0.06 against a street estimate of -0.07 — a beat of 14.3%.

Key statistics

Market cap

$56.1M

Forward P/E

1.0

P/B

4.20

Book value

$0.28

EPS (TTM)

$-0.26

52-week high

$1.57

52-week low

$0.69

50-day MA

$1.22

200-day MA

$1.01

Beta

0.68

Analyst view

Analysts rate Talphera Inc. a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $3.12.

Shareholding

Insiders

21.41%

Institutions

46.03%

Largest institutional holders

Fund	Stake
Nantahala Capital Management, LLC	13.46%
Rosalind Advisors, Inc.	9.96%
AIGH Capital Management, LLC	8.87%
Rock Springs Capital Management LP	6.91%
CANTOR FITZGERALD, L. P.	3.42%
Bleichroeder LP	2.52%
Dauntless Investment Group, LLC	1.44%
Vanguard Capital Management, LLC	1.35%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Talphera Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.